107 related articles for article (PubMed ID: 1377556)
1. The perfluorocarbon emulsion PFOB: potential indicator of change in blood volume using fluorine-19 NMR spectroscopy.
Thomas C; Counsell C; Sansom J; Wood P; Stratford I; Adams G
EXS; 1992; 61():362-7. PubMed ID: 1377556
[No Abstract] [Full Text] [Related]
2. Use of fluorine-19 nuclear magnetic resonance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice.
Thomas C; Counsell C; Wood P; Adams GE
J Natl Cancer Inst; 1992 Feb; 84(3):174-80. PubMed ID: 1542128
[TBL] [Abstract][Full Text] [Related]
3. Perfluorocarbon emulsions as intravenous delivery media for hyperpolarized xenon.
Wolber J; Rowland IJ; Leach MO; Bifone A
Magn Reson Med; 1999 Mar; 41(3):442-9. PubMed ID: 10204864
[TBL] [Abstract][Full Text] [Related]
4. Deuterium nuclear magnetic resonance imaging of the developmental pattern of tumour blood flow.
Burney IA; Maxwell RJ; Griffiths JR; Field SB
EXS; 1992; 61():357-61. PubMed ID: 1377555
[No Abstract] [Full Text] [Related]
5. [Use of fluorine-19 nuclear resonance spectroscopy for the measurement of changes induced in blood perfusion volume in experimental tumors in vivo].
Thomas C; Counsell C; Wood P; Adams G
Bull Cancer; 1993 Aug; 80(8):666-73. PubMed ID: 7515732
[TBL] [Abstract][Full Text] [Related]
6. Relationship of tumor blood flow with radiation and drug response.
Pallavicini MG; Hill RP
Int J Radiat Oncol Biol Phys; 1979 Oct; 5(10):1767-72. PubMed ID: 528239
[No Abstract] [Full Text] [Related]
7. Evidence for intermittent radiobiological hypoxia in experimental tumour systems.
Chaplin DJ; Trotter MJ; Durand RE; Olive PL; Minchinton AI
Biomed Biochim Acta; 1989; 48(2-3):S255-9. PubMed ID: 2730619
[TBL] [Abstract][Full Text] [Related]
8. Effects of vasodilators on the signal intensity of perfluorocarbon monitored by in vivo 19F-NMR spectroscopy.
Sogabe T; Imaizumi T; Mori T; Tominaga M; Koga K; Yabuuchi Y
Magn Reson Imaging; 1997; 15(3):341-5. PubMed ID: 9201682
[TBL] [Abstract][Full Text] [Related]
9. Changes in blood flow of growing experimental tumor determined by the clearance of 133Xe.
Siracká E; Pappová N; Pípa V; Durkovský J
Neoplasma; 1979; 26(2):173-7. PubMed ID: 582462
[TBL] [Abstract][Full Text] [Related]
10. Two-compartment radial diffusive exchange analysis of the NMR lineshape of (129)Xe dissolved in a perfluorooctyl bromide emulsion.
Gherase MR; Wallace JC; Cross AR; Santyr GE
J Chem Phys; 2006 Jul; 125(4):44906. PubMed ID: 16942191
[TBL] [Abstract][Full Text] [Related]
11. In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
Bremner JC; Counsell CJ; Adams GE; Stratford IJ; Wood PJ; Dunn JF; Radda GK
Br J Cancer; 1991 Nov; 64(5):862-6. PubMed ID: 1931606
[TBL] [Abstract][Full Text] [Related]
12. Glucose metabolism in RIF-1 tumors after reduction in blood flow: an in vivo 13C and 31P NMR study.
Bhujwalla ZM; Shungu DC; Chatham JC; Wehrle JP; Glickson JD
Magn Reson Med; 1994 Sep; 32(3):303-9. PubMed ID: 7984062
[TBL] [Abstract][Full Text] [Related]
13. Reduced blood flow increases the in vivo ammonium ion concentration in the RIF-1 tumor.
Constantinidis I; Gamcsik MP
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):143-9. PubMed ID: 7642412
[TBL] [Abstract][Full Text] [Related]
14. Hydralazine at thermoradiotherapy: tumor size and blood flow effects.
Kozin SV; Hasegawa T; Ha-Kawa SK; Akagi K; Tanaka Y
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):505-10. PubMed ID: 8005807
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis determines blood flow, metabolism, growth rate, and ATPase kinetics of tumors growing in an irradiated bed: 31P and 2H nuclear magnetic resonance studies.
Okunieff P; Dols S; Lee J; Singer S; Vaupel P; Neuringer LJ; Beshah K
Cancer Res; 1991 Jun; 51(12):3289-95. PubMed ID: 1710169
[TBL] [Abstract][Full Text] [Related]
16. A new perfluorocarbon for use in fluorine-19 magnetic resonance imaging and spectroscopy.
Sotak CH; Hees PS; Huang HN; Hung MH; Krespan CG; Raynolds S
Magn Reson Med; 1993 Feb; 29(2):188-95. PubMed ID: 8429782
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of hydralazine on tumor and normal tissue blood perfusion by MRI.
Belfi CA; Paul CR; Shan S; Ngo FQ
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):473-9. PubMed ID: 8005802
[TBL] [Abstract][Full Text] [Related]
18. Effect of tumor blood flow manipulations on radiation response.
Pallavicini MG; Hill RP
Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1321-5. PubMed ID: 6411662
[TBL] [Abstract][Full Text] [Related]
19. Relative change in blood volume following administration of hydralazine as monitored by 19F NMR spectroscopy.
Thomas C; Counsell CJ; Wood P; Adams GE
Int J Radiat Biol; 1991; 60(1-2):219-23. PubMed ID: 1677974
[No Abstract] [Full Text] [Related]
20. [Hydralazine-induced enhancement of hyperthermia treatment in vivo].
Oshima T; Akagi K; Hasegawa T; Tanaka Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Nov; 52(11):1582-8. PubMed ID: 1465339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
